[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $414mm Financial analysts are cautiously optimistic about the long-term potential of the topic, despite concerns about cash burn and dilution risk. ### About $414mm A financial topic related to a specific monetary value. ### Engagements: XX [#](/topic/$414mm/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$414mm/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XXX on 2025-07-17 **1-Year Low**: X on 2025-07-19 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$414mm/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$414mm/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1-Year High**: X on 2025-07-17 **1-Year Low**: X on 2025-07-17 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$414mm/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$414mm/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $414mm in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1-Year High**: X on 2025-07-17 **1-Year Low**: X on 2025-07-17 **Top assets mentioned** In the posts about $414mm in the last XX hours [SuperRare (RARE)](/topic/$rare) **Top topics mentioned** In the posts about $414mm in the last XX hours [$650mm](/topic/$650mm), [$550mm](/topic/$550mm), [longterm](/topic/longterm), [$rare](/topic/$rare) ### Top Social Posts [#](/topic/$414mm/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$RARE remains a moderate risk high-reward investment. The Orbit studys adherence to its 18-month timeline and their clean FDA approval record (4-for-4 no CRLs) strengthen its long-term potential in the rare disease space. UX111s delay is a manageable hurdle anticipated approval in 2026 - They have roughly $550mm in cash with $414mm burn and projected to do $650mm in revenue this year. Cash burn and potential dilution risk warrant caution. For risk-tolerant investors with a 24+ month horizon with a target of $65$85 by end-2026 if pipeline milestones are met. A Hold or Watch stance is prudent" [@ilzizzo](/creator/x/ilzizzo) on [X](/post/tweet/1945719305892659570) 2025-07-17 05:36:46 UTC 1724 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Financial analysts are cautiously optimistic about the long-term potential of the topic, despite concerns about cash burn and dilution risk.
A financial topic related to a specific monetary value.
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XXX on 2025-07-17
1-Year Low: X on 2025-07-19
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-07-17
1-Year Low: X on 2025-07-17
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $414mm in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1-Year High: X on 2025-07-17
1-Year Low: X on 2025-07-17
Top assets mentioned In the posts about $414mm in the last XX hours
Top topics mentioned In the posts about $414mm in the last XX hours
$650mm, $550mm, longterm, $rare
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$RARE remains a moderate risk high-reward investment. The Orbit studys adherence to its 18-month timeline and their clean FDA approval record (4-for-4 no CRLs) strengthen its long-term potential in the rare disease space. UX111s delay is a manageable hurdle anticipated approval in 2026 - They have roughly $550mm in cash with $414mm burn and projected to do $650mm in revenue this year. Cash burn and potential dilution risk warrant caution. For risk-tolerant investors with a 24+ month horizon with a target of $65$85 by end-2026 if pipeline milestones are met. A Hold or Watch stance is prudent"
@ilzizzo on X 2025-07-17 05:36:46 UTC 1724 followers, XXX engagements
/topic/$414mm